Patients under 21 with breast or colorectal cancer more likely to have aggressive disease
the ONA take:
According to two studies presented at the 2014 Clinical Congress of the American College of Surgeons in San Francisco, California, when breast and colorectal cancers occur in children, the diseases are aggressive.
Researchers at Seattle Children's Hospital in Seattle, Washington sought to investigate how breast cancer progresses when diagnosed in patients under age 21. Researchers identified 574 patients aged 21 or younger with breast cancer from the National Cancer Data Base of the American College of Surgeons and American Cancer Society. Results showed that younger patients were more likely to be African American, male, and uninsured.
Furthermore, these patients had worse outcomes that adult patients. Researchers also found a large delay between surgical treatment and radiation therapy. The delay is something the researchers hope to investigate further.
The other study was conducted by researchers at the Maine Medical Center in Portland, Maine who wanted to assess the outcomes of younger patients diagnosed with colorectal cancer. They identified 920 patients age 21 or younger. They found that younger patients were more likely diagnosed with advanced disease and found to have more aggressive tumors. Pediatric patients also had lower 5-year survival rates compared young adults.
When breast and colorectal cancers occur in children, the diseases are aggressive.
Breast and colorectal cancers rarely occur in children, but when they do, these conditions are more precarious, according to a pair of National Cancer Data Base (NCDB) studies presented this week at the 2014 Clinical Congress of the American College of Surgeons. Both breast cancer and colon cancer are known as adult conditions.
According to the American Cancer Society, 95 percent of new breast cancer cases occur in women age 40 and older. Colorectal cancer is also largely an adult cancer, with 90 percent of cases occurring in people who are age 50 and older.
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- Including Informal Caregivers of Elderly in Discharge Process Reduces Readmission Risk
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- CQGS Releases Standards for Surgical Care of Older Adults
- Radiation Protocol Deviations Linked to Worse Outcomes in Pediatric Brain Malignancy
- Use of Counseling, Surgery Rates Show Limited Physician Knowledge of Breast Cancer Genetic Testing
- Family History Does Not Exclude Active Surveillance as Treatment Option for Prostate Cancer
- Beans, Whole Grains in Diet Beneficial for Colorectal Cancer Survivors
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|